Cyclerion Therapeutics to Participate in Two Upcoming Investor Conferences
September 08 2021 - 8:00AM
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage
biopharmaceutical company on a mission to develop treatments that
restore cognitive function, today announced that Company management
will present at two upcoming investor conferences.
- H.C. Wainwright
23rd Annual Global Investment Conference September 13-15, 2021.
On-demand session is available starting at 7:00 a.m. EDT on
September 13th.
- Cantor Fitzgerald Virtual Global
Healthcare Conference, September 30, 2021 at 2:40 p.m. EDT.
The live webcasts can be accessed via the Investors & Media
section of the Cyclerion website at
https://ir.cyclerion.com/news-events/event-calendar. An archived
replay of the events will be available on the site for
approximately 90 days following the presentations.
About Cyclerion Therapeutics
Cyclerion Therapeutics is a clinical-stage biopharmaceutical
company on a mission to develop treatments that restore cognitive
function. Cyclerion is advancing novel, first-in-class,
CNS-penetrant, sGC stimulators that modulate a key node in a
fundamental CNS signaling pathway. The multidimensional
pharmacology elicited by the stimulation of sGC has the potential
to impact a broad range of CNS diseases. The most advanced
compound, CY6463 has shown rapid improvement in biomarkers
associated with cognitive function and is currently in clinical
development for Alzheimer's Disease with Vascular pathology (ADv)
and Mitochondrial Encephalomyopathy, Lactic Acidosis and
Stroke-like episodes (MELAS) and Cognitive Impairment Associated
with Schizophrenia (CIAS). Cyclerion is also advancing CY3018, a
next generation sGC stimulator.
For more information about Cyclerion, please visit
https://www.cyclerion.com/ and follow us on Twitter (@Cyclerion)
and LinkedIn (www.linkedin.com/company/cyclerion).
InvestorsCarlo Tanzi, Ph.D.Kendall Investor
Relationsctanzi@kendallir.com
MediaAmanda SellersVerge Scientific
Communicationsasellers@vergescientific.com
Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From Sep 2023 to Sep 2024